| 摘要 |
The invention relates to the use of one or more antigens for the preparation of vaccines according to Claim 17 of the main patent, characterised in that the antigen or antigens consist(s) of proteins which are non-immunogenic because their molecular weight is too low. The invention also relates to this protein rendered immunogenic by binding to a carrier, as well as to the pharmaceutical composition containing the aforementioned protein.
|
